Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study

BACKGROUND: This study was designed to assess the long-term safety and tolerability of a new flexible extended regimen of ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg, which allows management of intracyclic (breakthrough) bleeding [flexible management of intracyclic (breakthrough) bleeding (...

Descripción completa

Detalles Bibliográficos
Autores principales: Klipping, Christine, Duijkers, Ingrid, Fortier, Michel P, Marr, Joachim, Trummer, Dietmar, Elliesen, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353878/
https://www.ncbi.nlm.nih.gov/pubmed/22454004
http://dx.doi.org/10.1136/jfprhc-2011-100214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353878/
https://www.ncbi.nlm.nih.gov/pubmed/22454004
http://dx.doi.org/10.1136/jfprhc-2011-100214

Ejemplares similares